• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Hamilton Lane Incorporated

    8/27/25 4:33:06 PM ET
    $HLNE
    Investment Managers
    Finance
    Get the next $HLNE alert in real time by email
    DEFA14A 1 hlne-defa14axproxysuppleme.htm DEFA14A Document

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
     ___________________________________
    SCHEDULE 14A
    Proxy Statement Pursuant to Section 14(a) of
    the Securities Exchange Act of 1934
    (Amendment No. )
     ___________________________________
    Filed by the Registrant  ý
    Filed by a Party other than the Registrant  ¨
    Check the appropriate box:
    ¨
    Preliminary Proxy Statement
    ¨
    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
    ¨
    Definitive Proxy Statement
    ý
    Definitive Additional Materials
    ¨
    Soliciting Material under §240.14a-12

    HAMILTON LANE INCORPORATED
    ______________________________________________________________________________
    (Name of Registrant as Specified In Its Charter)

    _____________________________________________________________________________________________
    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

    Payment of Filing Fee (Check the appropriate box):
    ý
    No fee required.
    o
    Fee paid previously with preliminary materials.
    o
    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11






    HAMILTON LANE INCORPORATED

    SUPPLEMENT TO PROXY STATEMENT
    FOR THE ANNUAL MEETING OF STOCKHOLDERS
    TO BE HELD ON SEPTEMBER 4, 2025

    Explanatory Note

    On July 24, 2025, Hamilton Lane Incorporated (the “Company”) filed its Definitive Proxy Statement on Schedule 14A (the “Proxy Statement”) with the Securities and Exchange Commission and furnished it to stockholders in connection with the solicitation of proxies by the Company’s Board of Directors for use at the 2025 Annual Meeting of Stockholders of the Company to be held on September 4, 2025 (the “Annual Meeting”).

    The purpose of this supplement, dated August 27, 2025 (this “Supplement”), is solely to correct certain disclosures on pages 46 through 47 of the Proxy Statement as set forth below under the heading “Changes to the Proxy Statement.” Other than these changes, the Proxy Statement remains unchanged, and this Supplement does not otherwise modify, amend, supplement or affect the Proxy Statement.

    From and after the date of this Supplement, any references to the “Proxy Statement” are to the Proxy Statement as amended and supplemented by this Supplement. This Supplement should be read in conjunction with the Proxy Statement and the other proxy materials previously distributed for the Annual Meeting.

    Changes to the Proxy Statement

    The following disclosure (change marked, with new text bold and underlined and deleted text bold and strikethrough) amends and supplements the information provided in the fourth and fifth paragraphs in the section entitled “Executive Compensation—Potential Payments upon Termination or Change in Control—Equity Awards” beginning on page 46 of the Proxy Statement:

    For terminations not in connection with a Change in Control, the consequences vary by type of award and reason for termination. For restricted stock with time-based vesting, a termination of service due to death or disability results in accelerated vesting of unvested awards. A termination of service for cause, as defined in the 2017 Equity Plan or, if applicable, the grantee’s employment agreement, results in a forfeiture of all unvested restricted stock awards and allows our compensation committee to require disgorgement of any profit, gain or other benefit received from prior awards that vested up to 24 months prior to the termination for cause. A termination of service for any other reason results in a forfeiture of awards that are unvested at the time of termination. Therefore, a termination for a reason other than death or disability does not generally result in



    incremental vesting for grantees. In the past, however, our board of directors has approved the accelerated vesting of awards that would have otherwise been subject to forfeiture upon the departure of an executive. Requests for such accelerated vestings are considered by the board of directors on a case-by-case basis based on the executive's tenure, contributions to the Company and other factors deemed relevant to the board. For Performance Awards, the only other type of award that is currently outstanding, unless otherwise determined by our compensation committee, a termination of service for any reason (other than a termination due to death or disability) prior to the end of the performance period results in a forfeiture of all unvested Performance Awards with respect to such performance period, except as otherwise provided in a grantee’s employment agreement while a termination of service due to death or disability results in accelerated vesting of the full Performance Award (regardless of whether performance conditions have been achieved as of the date of such termination).

    Assuming a termination due to death or disability on March 31, 2025, Messrs. Delgado-Moreira, Hirsch and Armbrister and Mses. Kramer and Gavalis would have forfeited their outstanding Performance Awards, but each of our named executive officers would have been entitled to accelerated vesting of outstanding all time-based restricted stock awards and Performance Awards. Mr. Carl Accordingly, upon a termination due to death or disability, each of our named executive officers would have realized the same amounts as are set forth in the table above, Mr. Hirsch would have realized $7,688,023, Mr. Delgado-Moreira would have realized $6,617,004, Mr. Armbrister would have realized $1,232,920, Ms. Kramer would have realized $2,377,679, and Ms. Gavalis would have realized $630,955.

    Get the next $HLNE alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HLNE

    DatePrice TargetRatingAnalyst
    5/15/2025Outperform → Perform
    Oppenheimer
    1/21/2025$186.00Perform → Outperform
    Oppenheimer
    1/6/2025$139.00Neutral → Sell
    Goldman
    9/12/2024$156.00Equal Weight
    Wells Fargo
    4/11/2024$115.00Overweight → Neutral
    JP Morgan
    1/11/2024Outperform → Perform
    Oppenheimer
    5/26/2023$87.00Perform → Outperform
    Oppenheimer
    3/15/2023$85.00Neutral → Overweight
    JP Morgan
    More analyst ratings

    $HLNE
    SEC Filings

    View All

    Hamilton Lane Incorporated filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Hamilton Lane INC (0001433642) (Filer)

    9/5/25 4:29:27 PM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Incorporated filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Hamilton Lane INC (0001433642) (Filer)

    9/4/25 4:16:11 PM ET
    $HLNE
    Investment Managers
    Finance

    SEC Form 424B5 filed by Hamilton Lane Incorporated

    424B5 - Hamilton Lane INC (0001433642) (Filer)

    9/3/25 4:15:40 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hamilton Lane Launches Global Private Secondary Fund

    The global evergreen fund for secondaries investment seeks to offer a diversified portfolio of mature private equity investments positioned for value creation by leveraging the firm's 24+ years of experience in the secondary market and extensive scaleThis launch marks the 10th fund in Hamilton Lane's $12 billion+ AUM evergreen platformLONDON, Sept. 3, 2025 /PRNewswire/ -- Leading private markets investment firm Hamilton Lane (NASDAQ:HLNE) today announced the launch of the Hamilton Lane Global Private Secondary Fund ("HLGPS" or "the Fund"), an evergreen investment vehicle focused on the secondary market. The Fund is available to accredited high-net-worth investors and their advisors, as well

    9/3/25 2:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Announces Pricing of Public Offering of Class A Common Stock

    CONSHOHOCKEN, Pa., Sept. 2, 2025 /PRNewswire/ -- Private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) ("Hamilton Lane") today announced the pricing of an underwritten public offering by Hamilton Lane and a selling stockholder of 528,705 shares of Class A common stock, in the aggregate, for gross proceeds of approximately $77.5 million. The offering is expected to close on September 4, 2025, subject to customary closing conditions. Hamilton Lane intends to use the proceeds from the sale of its shares to settle in cash exchanges of membership units in Hamilton Lane Advisors, L.L.C. held by certain of its members. Hamilton Lane will not receive any proceeds from the s

    9/2/25 7:23:00 PM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Announces Public Offering of Class A Common Stock

    CONSHOHOCKEN, Pa., Sept. 2, 2025 /PRNewswire/ -- Private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) ("Hamilton Lane") today announced that it has commenced an underwritten public offering of 528,705 shares of Class A common stock, in the aggregate, to be sold by Hamilton Lane and a selling stockholder, subject to market and other conditions.  Hamilton Lane intends to use the proceeds from the sale of its shares to settle in cash exchanges of membership units in Hamilton Lane Advisors, L.L.C. held by certain of its members. Hamilton Lane will not receive any proceeds from the sale of shares by the selling stockholder. Accordingly, Hamilton Lane will not retain any

    9/2/25 4:08:00 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Hamilton Lane downgraded by Oppenheimer

    Oppenheimer downgraded Hamilton Lane from Outperform to Perform

    5/15/25 8:08:14 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Hamilton Lane from Perform to Outperform and set a new price target of $186.00

    1/21/25 7:49:57 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane downgraded by Goldman with a new price target

    Goldman downgraded Hamilton Lane from Neutral to Sell and set a new price target of $139.00

    1/6/25 8:11:18 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner French River 5 Ltd sold $21,976,500 worth of shares (150,000 units at $146.51), decreasing direct ownership by 31% to 330,015 units (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    9/8/25 5:42:00 PM ET
    $HLNE
    Investment Managers
    Finance

    Executive Co-Chairman Rogers Hartley R. disposed of $150 worth of Class B Common Stock (149,875 units at $0.00) (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    9/8/25 5:32:36 PM ET
    $HLNE
    Investment Managers
    Finance

    Large owner Hla Investments Llc disposed of $470 worth of Class B Common Stock (469,880 units at $0.00) (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    9/8/25 5:31:05 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Co-Chief Executive Officer Delgado-Moreira Juan bought $105,950 worth of shares (525 units at $201.81) (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    11/13/24 4:31:06 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/13/24 9:56:40 PM ET
    $HLNE
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/12/24 3:55:46 PM ET
    $HLNE
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/4/24 11:53:29 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Leadership Updates

    Live Leadership Updates

    View All

    Cosette Pharmaceuticals Appoints Jeff Neubig as Vice President, Quality and Regulatory Affairs

    -- Experienced Industry Leader to drive Cosette's Best-in-Class Quality Organization and facilitate Regulatory Approvals -- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has appointed Jeff Neubig as Vice President, Quality and Regulatory Affairs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250630266171/en/Jeff Neubig, VP, Quality & Regulatory Affairs, Cosette Pharmaceuticals In this critical role, Jeff will lead Cosette's best-in-class quality and regulatory affairs organizations, maintaining the company's rigorous quality standards and further establishing Co

    6/30/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Grenova Secures New Investment; Appoints Life Sciences Veteran to the Board

    Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova's board, and the successful completion of a new round of growth equity capital. These developments support Grenova's strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories worldwide. Ted Hull brings over 30 years of experience in the life sciences industry, including as a clinical lab CEO for the last 20+ years. In his role at Grenova, Mr. Hull is set to provide strategic leadership and to play a pivotal role in shaping the company's future. "I

    4/23/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations

    Industry leader with 35+ years of experience in manufacturing operations and global supply chain excellence Cosette Pharmaceuticals, Inc., a leading specialty pharmaceuticals company, today announced the appointment of Vincent (Vin) Colicchio as Senior Vice President of Operations, effective February 3, 2025. In this role, Vin will lead Cosette's manufacturing, global supply chain, and operational strategy, ensuring efficiency, and supply continuity as the company continues its strong trajectory of growth and transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250210366017/en/Senior Vice President, Operations (Photo

    2/10/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Financials

    Live finance-specific insights

    View All

    HAMILTON LANE INCORPORATED REPORTS FIRST QUARTER FISCAL 2026 RESULTS

    CONSHOHOCKEN, Pa., Aug. 5, 2025 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the first fiscal quarter ended June 30, 2025. The Company issued a full detailed presentation of its first quarter fiscal 2026 results, which can be accessed on the Company's Shareholders website at https://shareholders.hamiltonlane.com/ Dividend Hamilton Lane has declared a quarterly dividend of $0.54 per share of Class A common stock to record holders at the close of business on September 19, 2025 that will be paid on October 6, 2025. The target full-year dividend of $2.16 represents a 10% increase from the prior fiscal year

    8/5/25 7:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Incorporated to Announce First Quarter Fiscal 2026 Results on August 5, 2025

    CONSHOHOCKEN, Pa., July 15, 2025 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the first fiscal quarter ended June 30, 2025 before the market opens on Tuesday, August 5, 2025. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/. Hamilton Lane will host a conference call via webcast at 11:00 a.m. ET on August 5 to discuss the results for the first fiscal quarter. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website by clicking here (https://shareholders.hamiltonlane.com/) at least 15 minut

    7/15/25 7:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    HAMILTON LANE INCORPORATED REPORTS STRONG FOURTH FISCAL QUARTER AND FISCAL YEAR 2025 RESULTS, WITH MANAGEMENT AND ADVISORY FEES GROWING BY 14% AND ASSETS UNDER MANAGEMENT GROWING BY 11% YEAR-OVER-YEAR

    CONSHOHOCKEN, Pa., May 29, 2025 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the fourth fiscal quarter and full fiscal year ended March 31, 2025. FISCAL YEAR 2025 HIGHLIGHTS Assets under management – Total assets under management of $138 billion grew 11% year-over-year. Fee-earning assets under management increased 10% to $72 billion over the same period.Revenue – Management and advisory fees increased 14% to $513.9 million for fiscal 2025.Carried Interest – Unrealized carried interest balance of $1.3 billion was up 3% year-over-year.Earnings per share – GAAP EPS of $5.41 on $217.4 million of GAAP net i

    5/29/25 7:08:00 AM ET
    $HLNE
    Investment Managers
    Finance